Sonic Healthcare Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	9,645	8,967	8,169	9,340	8,754
Revenue Growth (YoY)	7.56%	9.77%	-12.54%	6.69%	28.14%
Cost of Revenue	6,457	6,023	5,327	5,614	5,328
Gross Profit	3,188	2,945	2,842	3,726	3,426
Selling, General & Admin	267.56	249.79	217.02	206.13	247.72
Amortization of Goodwill & Intangibles	92.85	82.92	71.63	67.99	68.2
Other Operating Expenses	1,169	1,068	904.26	687.67	615.78
Operating Expenses	2,252	2,095	1,824	1,569	1,505
Operating Income	936.19	849.66	1,018	2,157	1,921
Interest Expense	-180.51	-151.35	-87.03	-79.82	-92.52
EBT Excluding Unusual Items	755.69	698.31	931.19	2,077	1,829
Merger & Restructuring Charges	-4.82	-	-	-	-
Gain (Loss) on Sale of Assets	-	32.34	-	-	-
Pretax Income	750.87	730.65	931.19	2,077	1,829
Income Tax Expense	206.94	186.85	223.26	561.74	480.94
Earnings From Continuing Operations	543.92	543.8	707.93	1,515	1,348
Minority Interest in Earnings	-30.33	-32.71	-22.95	-54.9	-32.62
Net Income	513.6	511.09	684.98	1,461	1,315
Net Income to Common	513.6	511.09	684.98	1,461	1,315
Net Income Growth	0.49%	-25.39%	-53.10%	11.07%	149.18%
Shares Outstanding (Basic)	480	476	470	478	477
Shares Outstanding (Diluted)	481	477	472	483	481
Shares Change (YoY)	0.91%	0.96%	-2.16%	0.29%	0.90%
EPS (Basic)	1.07	1.07	1.46	3.05	2.75
EPS (Diluted)	1.07	1.07	1.45	3.02	2.73
EPS Growth	-0.47%	-26.07%	-52.07%	10.76%	146.93%
Free Cash Flow	960.55	600.9	1,082	1,939	1,769
Free Cash Flow Per Share	2.00	1.26	2.29	4.01	3.67
Dividend Per Share	1.070	1.060	1.040	1.000	0.910
Dividend Growth	0.94%	1.92%	4.00%	9.89%	7.06%
Gross Margin	33.05%	32.84%	34.80%	39.90%	39.14%
Operating Margin	9.71%	9.47%	12.46%	23.09%	21.95%
Profit Margin	5.33%	5.70%	8.38%	15.64%	15.02%
Free Cash Flow Margin	9.96%	6.70%	13.24%	20.76%	20.21%
EBITDA	1,244	1,152	1,281	2,413	2,159
EBITDA Margin	12.90%	12.84%	15.68%	25.83%	24.66%
D&A For EBITDA	307.58	301.97	262.67	255.73	237.94
EBIT	936.19	849.66	1,018	2,157	1,921
EBIT Margin	9.71%	9.47%	12.46%	23.09%	21.95%
Effective Tax Rate	27.56%	25.57%	23.98%	27.04%	26.30%
Revenue as Reported	9,645	9,000	8,169	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.